(Q33151135)

22 July 2017

title

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis (English)

1 reference

Primary systemic amyloidosis

22 July 2017

0 references

1 reference

1

Angela Dispenzieri

1 reference

22 July 2017

9

Robert A Kyle

1 reference

22 July 2017

2

Martha Q Lacy

1 reference

22 July 2017

3

S Vincent Rajkumar

1 reference

22 July 2017

10

Morie A Gertz

1 reference

22 July 2017

7

John A Lust

1 reference

22 July 2017

5

Thomas E Witzig

1 reference

22 July 2017

8

Philip R Greipp

1 reference

22 July 2017

4

Susan M Geyer

1 reference

22 July 2017

Rafael Fonseca

6

1 reference

22 July 2017

publication date

1 December 2003

1 reference

22 July 2017

1 reference

22 July 2017

volume

10

1 reference

22 July 2017

issue

4

1 reference

22 July 2017

page(s)

257-261

1 reference

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Thalidomide for previously untreated indolent or smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120309041743

10.3109/13506120309041743

21 January 2018

Identifiers

DOI

1 reference

22 July 2017

1 reference